CS14-085 Autolytic Debridement and Healing of Neonatal and Pediatric Wounds with Active Leptospermum Honey

Rene Amaya, MD, Pediatric Infectious Disease Specialists of Houston, Houston, TX





The purpose of this presentation is to illustrate the effectiveness of debridement and wound progression with Active Leptospermum Honey (ALH) in neonatal and pediatric wound care.   



To establish and demonstrate the safe and timely debridement and wound progress the use of ALH affords the neonatal and pediatric practitioner.



Case #1: Male, 23 week old neonate with NICU complications involving respiratory distress, acidosis, hypotension needing support with dopamine and hydrocortisone, multiple episodes of sepsis, bilateral hernia repair, and multiple wounds. Pt. developed dry, eschar necrosis of left toes. Surgeon recommended amputation of toes. ALH TX initiated. Outcome:  Eschar debrided within 2 weeks and no amputation required. All toes viable.

Case #2: Female, 29 week old neonate with wound on left forearm due to IV infiltrate. Wound measured 1.5 x 1.6 with 100% slough and peri-wound erythema. Treatment had been hydrogel sheet dressing. ALH dressing initiated and changed QOD.    Outcome:  The ALH provided effective alternative. Slough debrided within 7 days.

Case #3: Female, 15 yrs. developed severe right-sided facial cellulitis and vesicular and ulcerative lesions measuring 8 cm x 8 cm with depth ranging from 0.1 to 0.3 cm. Wound bed was 100% slough or hyperpigmented eschar. Multiple full thickness and partial thickness open wounds scattered over right side of face with edema and erythema. Tests revealed no clear etiology to explain the infection. ALH initiated 11-12-12 Outcome: As of 11-21 all eschar removed with 50 % slough remaining, no residual crusting, granulation 50% and healing in progress.

Photos will be presented.



 All cases demonstrated desired debridement and progressed well in the healing process.





Active Leptospermum Honey provided fast, safe, and effective debridement and wound progress for this sensitive group of young patients.